Existing treatment strategies for IBD primarily revolve around the use of anti-inflammatory medications, such as corticosteroids and formulations based on 5-aminosalicylic acid, azathioprine, and TNF-α inhibitors, including biological agents [6,7]. Here, TNF is linked to inflammatory bowel disease.